In the era of hyper-ageing, Creutzfeldt-Jakob disease (CJD) can become more prevalent as an important cause of dementia. This study aimed to evaluate the trends in crude and age-adjusted CJD-associated mortality and incidence rates in Japan using national vital statistics data on CJD-associated deaths among individuals aged over 50 years, as well as the government-funded nationwide CJD surveillance data (pertaining to the years 2005-2014) in Japan. The data were analysed using the Joinpoint Regression Program to estimate the long-term trends and average annual percentage changes (AAPCs). Overall, the AAPCs of age-adjusted CJD-associated mortality rates rose significantly over the study period (3.2%; 95% confidence interval [CI] 1.4-5.1%). T...
BackgroundPrion diseases are a family of rare, progressive, neurodegenerative disorders that affect ...
BackgroundCurrent projections of the scale of the coming dementia epidemic assume that the age- and ...
This is the author accepted manuscript. The final version is available from Springer Nature via the ...
In the era of hyper-ageing, Creutzfeldt-Jakob disease (CJD) can become more prevalent as an importan...
Creutzfeldt-Jakob disease (CJD) is a fatal disease presenting with rapidly progressive dementia, and...
The trends and current incidence of Creutzfeldt-Jakob disease (CJD) was examined by using a unique a...
From 1998 a prospective surveillance study of Creutzfeldt-Jakob disease (CJD) has been initiated in ...
After a cluster of Creutzfeldt-Jakob disease (CJD) cases among unusually young patients was reported...
Ageing is the greatest risk factor for most forms of dementia. Variant Creutzfeldt-Jakob Disease (v...
The aim of this study was to quantify the improvements in case ascertainment which are considered to...
International audienceSporadic Creutzfeldt-Jakob disease (sCJD) is the most common form of prion dis...
Dementia is a major public health concern in ageing societies. Although the population of Japan is a...
From Springer Nature via Jisc Publications RouterHistory: received 2022-02-23, accepted 2022-07-04, ...
textabstractCREUTZFELDT-JAKOB DISEASE (CJO) is a rare neurodegenerative disorder with a highly inter...
Dementia is a major public health concern in ageing societies. Although the population of Japan is a...
BackgroundPrion diseases are a family of rare, progressive, neurodegenerative disorders that affect ...
BackgroundCurrent projections of the scale of the coming dementia epidemic assume that the age- and ...
This is the author accepted manuscript. The final version is available from Springer Nature via the ...
In the era of hyper-ageing, Creutzfeldt-Jakob disease (CJD) can become more prevalent as an importan...
Creutzfeldt-Jakob disease (CJD) is a fatal disease presenting with rapidly progressive dementia, and...
The trends and current incidence of Creutzfeldt-Jakob disease (CJD) was examined by using a unique a...
From 1998 a prospective surveillance study of Creutzfeldt-Jakob disease (CJD) has been initiated in ...
After a cluster of Creutzfeldt-Jakob disease (CJD) cases among unusually young patients was reported...
Ageing is the greatest risk factor for most forms of dementia. Variant Creutzfeldt-Jakob Disease (v...
The aim of this study was to quantify the improvements in case ascertainment which are considered to...
International audienceSporadic Creutzfeldt-Jakob disease (sCJD) is the most common form of prion dis...
Dementia is a major public health concern in ageing societies. Although the population of Japan is a...
From Springer Nature via Jisc Publications RouterHistory: received 2022-02-23, accepted 2022-07-04, ...
textabstractCREUTZFELDT-JAKOB DISEASE (CJO) is a rare neurodegenerative disorder with a highly inter...
Dementia is a major public health concern in ageing societies. Although the population of Japan is a...
BackgroundPrion diseases are a family of rare, progressive, neurodegenerative disorders that affect ...
BackgroundCurrent projections of the scale of the coming dementia epidemic assume that the age- and ...
This is the author accepted manuscript. The final version is available from Springer Nature via the ...